Literature DB >> 9050999

GRS, a novel member of the Bcl-2 gene family, is highly expressed in multiple cancer cell lines and in normal leukocytes.

J J Kenny1, T J Knobloch, M Augustus, K C Carter, C A Rosen, J C Lang.   

Abstract

Our laboratory previously described the independent isolation of the fibroblast growth factor 4 (FGF-4) gene by NIH3T3 transformation assay using DNA from a patient with CML leukemia (Lucas et al., 1994). The FGF-4 gene was truncated by DNA rearrangement with a novel gene named GRS. In this manuscript we describe isolation of GRS cDNA and show by sequence comparison that GRS is a novel member of the Bcl-2 gene family. Northern analysis shows expression of the gene in normal human tissue to be largely restricted to the hematopoietic compartment. Analysis of the pattern of gene expression in cancer cell lines demonstrates GRS is expressed in hematopoietic malignancies and in melanoma. The chromosomal location of GRS has also been determined. The gene is positioned on chromosome 15 within bands q24-25.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9050999     DOI: 10.1038/sj.onc.1200898

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  14 in total

Review 1.  BCL2A1: the underdog in the BCL2 family.

Authors:  M Vogler
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

2.  Highly conserved caspase and Bcl-2 homologues from the sea anemone Aiptasia pallida: lower metazoans as models for the study of apoptosis evolution.

Authors:  Simon R Dunn; Wendy S Phillips; Joseph W Spatafora; Douglas R Green; Virginia M Weis
Journal:  J Mol Evol       Date:  2006-06-10       Impact factor: 2.395

3.  Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.

Authors:  Pamela M Pegman; Sinéad M Smith; Brendan N D'Souza; Sinéad T Loughran; Sabine Maier; Bettina Kempkes; Paul A Cahill; Matthew J Simmons; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

Review 4.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

5.  A strategy to identify genes associated with circulating solid tumor cell survival in peripheral blood.

Authors:  M V Fournier; M G Carvalho; A B Pardee
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

6.  NF-kappa B-dependent assembly of an enhanceosome-like complex on the promoter region of apoptosis inhibitor Bfl-1/A1.

Authors:  Leonard C Edelstein; Lynn Lagos; Matthew Simmons; Hemamalini Tirumalai; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

7.  The bfl-1 gene is transcriptionally upregulated by the Epstein-Barr virus LMP1, and its expression promotes the survival of a Burkitt's lymphoma cell line.

Authors:  B D'Souza; M Rowe; D Walls
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Activation of human monocytes induces differential resistance to apoptosis with rapid down regulation of caspase-8/FLICE.

Authors:  L P Perera; T A Waldmann
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

9.  Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

Authors:  Brendan N D'Souza; Leonard C Edelstein; Pamela M Pegman; Sinéad M Smith; Sinéad T Loughran; Ann Clarke; Anja Mehl; Martin Rowe; Céline Gélinas; Dermot Walls
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 10.  A1/Bfl-1 in leukocyte development and cell death.

Authors:  Eleonora Ottina; Denise Tischner; Marco J Herold; Andreas Villunger
Journal:  Exp Cell Res       Date:  2012-02-04       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.